Faculty Articles

Title

Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women

Publication Title

P T

Volume

42

Issue

4

Publication Date / Copyright Date

4-1-2017

First Page

237

Last Page

241

Abstract

Flibanserin (Addyi) for female sexual interest/arousal disorder in premenopausal women.

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Peer Reviewed

Find in your library

Share

 
COinS